Didecyldimethylammonium chloride (DDAC) for use in biocidal products-types 1 and 2 will be soon approved
Regulatory Updates1 June 2022
The European Commission notified the World Trade Organisation (WTO) about the draft publication on Commission Implementing Regulation that will approve the didecyldimethylammonium chloride (DDAC) as an active substance for use in biocidal products of product-types 1 and 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council.
DDAC used in biocidal product-types 1
A specific condition for its authorization is marked on the draft as it shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance.
DDAC used in biocidal product-types 2
The authorisation of biocidal products includes specific conditions as the product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorization, but not addressed in the Union level risk assessment of the active substance, and also to the exposure and potential risks for professional users.
1 February 2024
The didecyldimethylammonium chloride as an active substance for use in biocidal products of product-types 1 and 2 will be approved the 1st February 2024.
How Mérieux NutriSciences can support you?
Our experts and Mérieux NutriSciences GLP facility can support you in ensuring the effectiveness and safety of your products dedicated for healthcare professionals and individuals.